Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
KAZIA THERAPEUTICS TO PARTICIPATE IN EDISON GROUP'S GLOBAL HEALTHCARE 'OPEN HOUSE' VIRTUAL CONFERENCE 2022-01-25 21:00
Senhwa's Pidnarulex Receives US FDA Fast Track Designation for the Treatment of Solid Tumors with BRCA1/2, PALB2 and other HR Gene Mutations 2022-01-25 20:00
Sequanta selects Olink® Explore 3072 to analyze new cohort study in China 2022-01-25 19:36
2022 Japan Prize Laureates Announced 2022-01-25 14:00
ImmVira's New-Generation Vector Poised to Enable CAR-T Treatment for Solid Tumors 2022-01-25 08:30
Kintor Pharma Announced Successful Dosing of the First Patient for Acne Vulgaris Phase II Clinical Trial of KX-826 2022-01-24 21:47
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2021 Financial Results 2022-01-24 16:25
Harbour BioMed Announces Dosing of First Patient in Combination Therapy Phase Ib/IIa Trial of Next-Generation Anti-CTLA-4 Antibody 2022-01-24 15:39
HanAll Biopharma Reports Full-Year 2021 Results and Provides Business Update 2022-01-20 22:00
Hinova Announces First Patient Dosed in a Phase I Clinical Trial of HP518, an Orally Bioavailable Chimeric Degrader Targeting Androgen Receptor for Prostate Cancer Treatment 2022-01-20 20:28
Senhwa's Silmitasertib Receives US FDA Orphan Drug Designation for the Treatment of Biliary Tract Cancer 2022-01-20 20:00
Nippon Express (Belgium) Acquires GDP Certification for Facility in Brussels Airport's Cargo Area 2022-01-20 15:00
Neurophth Therapeutics Receives IND Clearance to Initiate Clinical Trial for China AAV-ND4 Gene Therapy NR082 in Leber Hereditary Optic Neuropathy 2022-01-19 22:30
Qilian International Holding Group Limited Receives Approval for the Sale of its Newly Developed Nitrofurantoin Enteric-coated Tablets 2022-01-19 20:30
ImmVira's MVR-T3011 IV completed first 2 cohorts dose-escalation of U.S. Phase I clinical study with favorable safety data 2022-01-19 08:30
I-Mab Announces First Patient Dosed in China Phase 2 Combination Trial of Lemzoparlimab with Toripalimab in Patients with Advanced Solid Tumors 2022-01-18 21:00
CN Energy Signs Operation & Management Agreement; Enters Multi-Billion Dollar Pharmaceutical Excipients Market 2022-01-18 21:00
MindRank Begins IND-enabling Studies of its first AI-designed Drug, 8 Months After Program Initiation 2022-01-18 17:17
InnoCare and Keymed Jointly Announce Dosing of First Patient in Clinical Trial of CD20xCD3 Bispecific Antibody CM355 2022-01-18 14:51
WuXi Biologics Completes GMP Inspection by South Korea's Ministry of Food and Drug Safety for Drug Substance Facility 2022-01-18 10:50
1 86 87 88 89 90 165